Ledger.Open graph →
SEC Form D · filed November 7, 2022

Taysha Gene Therapies, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kamran B. Alam · Dallas, TXExecRa Session Ii · Dallas, TXExec · DirectorSukumar B. Nagendran · Dallas, TXDirectorRa Session Ii · Dallas, TXExec · DirectorLaura B. Sepp-Lorenzino · Dallas, TXDirectorSukumar B. Nagendran · Dallas, TXDirectorSean P. Nolan · Morrisville, NCDirectorKathleen B. Reape · Dallas, TXDirectorSean P. Nolan · Morrisville, NCDirectorKamran B. Alam · Dallas, TXExecKathleen B. Reape · Dallas, TXDirectorPaul B. Manning · Berkeley, CADirectorLaura B. Sepp-Lorenzino · Dallas, TXDirectorPhillip B. Donenberg · Dallas, TXDirectorPaul B. Manning · Berkeley, CADirectorSuyash B. Prasad · Dallas, TXExecPhillip B. Donenberg · BUFFALO GROVE, ILDirectorSuyash B. Prasad · Dallas, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗